HIP questionnaire scores of participating patients by GW and HPV-related diagnosis in South Korea
| Men (n=150) | ES | P value | Women (n=250)* | ES | P value | |||
| With GW (n=75) | No GW (n=75) | HPV disease (n=200) | No HPV disease (n=50) | |||||
| HIP total score | ||||||||
| Mean | 50.90 | 36.13 | 1.69 | <0.0001 | 53.37 | 44.98 | 0.68 | <0.0001 |
| 95% CI | (48.8 to 53.0) | (34.3 to 38.0) | (51.8 to 55.0) | (41.4 to 48.6) | ||||
| Valid, n | 75 | 75 | 199 | 50 | ||||
| Worries and concerns | ||||||||
| Mean | 49.65 | 24.25 | 1.51 | <0.0001 | 57.19 | 41.94 | 0.63 | <0.0001 |
| 95% CI | (45.5 to 53.8) | (20.8 to 27.7) | (54.2 to 60.2) | (35.5 to 48.4) | ||||
| Valid, n | 75 | 75 | 199 | 49 | ||||
| Emotional impact | ||||||||
| Mean | 49.10 | 33.98 | 1.19 | <0.0001 | 56.08 | 42.32 | 0.84 | <0.0001 |
| 95% CI | (46.0 to 52.2) | (31.3 to 36.6) | (53.8 to 58.4) | (37.8 to 46.8) | ||||
| Valid, n | 75 | 75 | 199 | 50 | ||||
| Sexual impact | ||||||||
| Mean | 47.53 | 41.20 | 0.51 | 0.0019 | 50.81 | 49.80 | 0.07 | 0.6550 |
| 95% CI | (45.1 to 50.0) | (38.1 to 44.3) | (48.9 to 52.8) | (45.3 to 54.3) | ||||
| Valid, n | 75 | 75 | 197 | 49 | ||||
| Self-Image | ||||||||
| Mean | 49.00 | 41.63 | 0.76 | <0.0001 | 47.66 | 45.17 | 0.19 | 0.2226 |
| 95% CI | (46.5 to 51.5) | (39.8 to 43.5) | (45.9 to 49.5) | (41.4 to 48.9) | ||||
| Valid, n | 75 | 75 | 199 | 50 | ||||
| Partner issues and transmission | ||||||||
| Mean | 62.16 | 42.12 | 1.40 | <0.0001 | 58.86 | 47.23 | 0.62 | 0.0001 |
| 95% CI | (59.1 to 65.2) | (38.5 to 45.8) | (56.2 to 61.5) | (41.8 to 52.6) | ||||
| Valid, n | 74 | 66 | 185 | 47 | ||||
| Interactions with doctors | ||||||||
| Mean | 51.31 | 33.28 | 0.90 | <0.0001 | 46.75 | 45.73 | 0.20 | 0.6611 |
| 95% CI | (47.4 to 55.3) | (25.2 to 41.4) | (44.8 to 48.7) | (40.8 to 50.6) | ||||
| Valid, n | 71 | 30 | 199 | 50 | ||||
| Control-life impact | ||||||||
| Mean | 49.69 | 52.13 | 0.23 | 0.1643 | 48.48 | 52.37 | 0.31 | 0.0641 |
| 95% CI | (47.3 to 52.0) | (49.6 to 54.7) | (46.6 to 50.4) | (49.2 to 55.5) | ||||
| Valid, n | 75 | 75 | 199 | 50 | ||||
| HIP total score categorised | ||||||||
| No or little impact | 11 (14.7%) | 51 (68.0%) | <0.0001 | 23 (11.5%) | 17 (34.0%) | 0.0004 | ||
| Moderate impact | 64 (85.3%) | 24 (32.0%) | 168 (84.0%) | 30 (60.0%) | ||||
| Heavy psychological impact | 9 (4.5%) | 3 (6.0%) | ||||||
| Valid, n | 75 | 75 | 200 | 50 | ||||
HIP items range from 0 (lowest impact) to 10 points (highest impact).
CECA scores range from 0 (worst HRQoL) to 100 (the best HRQoL).
EQ-5D range from 0 (worst imaginable health state) to 100 (best imaginable health state).
ES >0.01 is considered significant.
*HPV, human papillomavirus is included in this table.
CECA, Cuestionario Especifico en Condilomas Acuminados; EQ-5D, EuroQol-5 Dimension; ES, effective size; GW, genital warts; HIP, Human Papillomavirus Impact Profile; HRQoL, health-related quality of life.